Study aims to identify single cell immune signatures of disease activity and treatment response to support clinical care PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc (TXG).
Study aims to identify single cell immune signatures of disease activity and treatment response to support clinical care Autoimmune diseases remain among the most challenging conditions to diagnose ...
PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results